corona virus (terrorism folder)

so...back to war, wedensady, 14.25 pm.

Let's get a sample of Covid 19...you need a saliva sample, and this kit. If you want to proceed to atypical uncurable pneumonia, you might use it also

QIAGEN.COM

QIAamp Viral RNA Mini Kit - QIAGEN Online Shop

For isolation of viral RNA from cell-free body fluids

corona virus

gd morning, welcome back to war, wednesday, 09.15 am
"The regulator had previously set a Feb. 4, 2020, target date for a decision on the Alnylam drug."
"The first RNAi drug, Alnylam Pharmaceuticals’ Onpattro (patisiran), was FDA-approved last August and it is showing long-term efficacy and sustained treatment for the rare disease hereditary transthyretin-mediated amyloidosis (hATTR amyloidosis). In addition to its fully stocked pipeline, Alnylam now has its eyes set on the next possible FDA approval, with the FDA granting priority review to their investigational RNAi drug for the rare disease acute hepatic porphyria, givosiran"

An Alnylam Pharmaceuticals drug developed to treat a rare, inherited metabolic disorder won FDA approval on Wednesday, the second regulatory nod the

XCONOMY.COM

Xconomy: Alnylam Gets Quick FDA OK for Second RNAi Rare Disease Drug

An Alnylam Pharmaceuticals drug developed to treat a rare, inherited metabolic disorder won FDA approval on Wednesday, the second regulatory…

An Alnylam Pharmaceuticals drug developed to treat a rare, inherited metabolic disorder won FDA approval on Wednesday, the second regulatory nod the

7 comentários

Gosto

Comentar

Partilhar

Comentários

• 

  Elsinha David One way to alter protein production via RNA is using RNA interference (RNAi), where a small strand of RNA acts as the biological drug by binding to mRNA in a cell and preventing it’s translation into a protein. This process effectively knocks down the mRNA so that no protein is produced. Since RNAi was the topic of the 2006 Nobel Prize in Physiology or Medicine,

  • Gosto
  •  · Responder
  •  · 3 min
• 

  Elsinha David Givosiran employs a gene-silencing technique called RNA interference (RNAi). Alnylam says its drug reduces to near-normal levels the toxic enzymes that prompt AHP attacks

  • Gosto
  •  · Responder
  •  · 2 min
• 

  Elsinha David What's the issues, the Lab scientistcs talk Google ...

  • Gosto
  •  · Responder
  •  · 1 min
• 

  Elsinha David FDA still afraid of the toxity

  • Gosto
  •  · Responder
  •  · 1 min
  •  · Editado(s)
• 

  Elsinha David price for this...700 euros not less for commercial purposes Mark

  • Gosto
  •  · Responder
  •  · 1 min
  •  · Editado(s)
• 

  Elsinha David this means ...make the accounting, on a small country, 10 million citzens, 7 billion

  • Gosto
  •  · Responder
  •  · 1 min
• 

  Elsinha David the PIB of 3 years is not enough
•